← back to search

Jingjing Zhao

Fujian Normal University · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, Circular RNAs in diseases, MicroRNA in disease regulation, and RNA Research and Splicing.
h-index
33
citations
4,877
works
144
NIH funding
primary concept
Medicine
email

Recent publications

Molecular order manipulation with dual additives suppressing trap density in non-fullerene acceptors enables efficient bilayer organic solar cells
Energy & Environmental Science 2025cited by 46position: middledoi
Boosting Binary Organic Solar Cells Over 20% Efficiency via Synchronous Modulation of Charge Transport and Phase Morphology
Advanced Energy Materials 2025cited by 11position: middledoi
Enhancing efficiency in organic electronics <i>via</i> J-aggregation modulation with non-halogenated solvents
Journal of Materials Chemistry C 2025cited by 7position: middledoi
Optimizing the ionization-energy offset for enhanced photovoltaic properties in bilayer organic solar cells
Physical Review Applied 2025cited by 7position: middledoi
Genomic characterization of normal and aberrant human milk production
Science Advances 2025cited by 3position: middledoi
Enhancing Adhesion and Reducing Charge Extraction Barrier Achieves 19.32% Efficiency in Inverted Organic Solar Cells with a Laminated Active Layer
Small 2025cited by 2position: middledoi
Dual-Donor-Induced Crystallinity Modulation Enables 19.23% Efficiency Organic Solar Cells
Nano-Micro Letters 2024cited by 36position: middledoi
A base editor for the long-term restoration of auditory function in mice with recessive profound deafness
Nature Biomedical Engineering 2024cited by 26position: middledoi
Modulating Acceptor Phase Leads to 19.59% Efficiency Organic Solar Cells
Advanced Science 2024cited by 21position: middledoi
Suppressing Nongeminate Charge Recombination Triggers 19.5% Efficiency Bilayer Organic Solar Cells
ACS Materials Letters 2024cited by 14position: middledoi
N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling
iScience 2024cited by 3position: middledoi
Inorganic Sonosensitizers for Sonodynamic Therapy in Cancer Treatment
Small 2023cited by 138position: middledoi
Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination <sup>1</sup>
Emerging Microbes & Infections 2023cited by 29position: middledoi
Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma
Journal of Hematology & Oncology 2023cited by 1position: middledoi
N6-Methyladenosine-Modified VGLL1 Promotes Ovarian Cancer Metastasis Through HMGA1/Wnt/β-Catenin Signaling
SSRN Electronic Journal 2023cited by 0position: middledoi
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
Journal for ImmunoTherapy of Cancer 2022cited by 163position: middledoi
OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis
Journal of Experimental & Clinical Cancer Research 2022cited by 74position: middledoi
Long Noncoding RNA RP11-732M18.3 Promotes Glioma Angiogenesis by Upregulating VEGFA
Frontiers in Oncology 2022cited by 6position: middledoi
N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through HMGA1/Wnt/β-catenin signaling
Research Square 2022cited by 1position: middledoi
Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression
Hepatology 2021cited by 336position: middledoi
Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study
OncoImmunology 2021cited by 105position: middledoi
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
Journal for ImmunoTherapy of Cancer 2021cited by 93position: middledoi
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin
Cell Death and Disease 2021cited by 29position: middledoi
Long non‑coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway
International Journal of Molecular Medicine 2021cited by 12position: lastdoi
lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR‑101/EZH2 axis in oral squamous cell carcinoma
Oncology Letters 2020cited by 33position: middledoi
TTDA inhibited apoptosis by regulating the p53-Bax/Bcl2 axis in glioma
Experimental Neurology 2020cited by 32position: middledoi
Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma
International Immunopharmacology 2020cited by 30position: middledoi
Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03)
Annals of Translational Medicine 2020cited by 4position: middledoi
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
Gut 2019cited by 267position: middledoi
Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma
Aging 2019cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qiuzhong Pan · Shanghai Children's Medical Center11 papers (2019–2024)Desheng Weng · State Key Laboratory of Oncology in South China10 papers (2019–2024)Jian‐Chuan Xia · Sun Yat-sen University8 papers (2019–2024)Zhipeng Kan · Guangxi University8 papers (2024–2025)Tong Xiang · Southwest Jiaotong University8 papers (2021–2024)Kilwon Cho · King Abdullah University of Science and Technology7 papers (2024–2025)Sein Chung · King Abdullah University of Science and Technology7 papers (2024–2025)Zhenmin Zhao · Guangxi University6 papers (2024–2025)Lixing Tan · Guangxi University6 papers (2024–2025)Yan Tang · Qingdao University5 papers (2019–2022)Jieying Yang · Chongqing University5 papers (2019–2023)Chaopin Yang · Sun Yat-sen University Cancer Center5 papers (2019–2023)Chun‐Min Kang · Guangzhou University of Chinese Medicine4 papers (2018–2022)Yue Huang · Taipei Medical University4 papers (2019–2022)Mengjia Song · Sun Yat-sen University4 papers (2019–2023)Xingyu Jiang · Tongji University4 papers (2022–2024)Liming Cai · Sun Yat-sen University Cancer Center4 papers (2022–2024)Yuan Liu · Beijing Institute of Technology4 papers (2024–2025)Yanna Zhang · Guangzhou University of Chinese Medicine4 papers (2022–2024)Qijing Wang · Sun Yat-sen University Cancer Center3 papers (2021–2022)